NYSE · CIK 0001644903
YCBD cbdMD, Inc.
Insider trading from SEC Form 4. Last filing Dec 19, 2025. Close $0.39 on Oct 9, 2026, 0% from the 52-week low and -83% from the high.
cbdMD, Inc. (YCBD) has 11 SEC Form 4 filings on file from 8 insiders, the latest filed on Dec 19, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
1 open-market trade has been scored at YCBD. The newest: Clark R. Crosnoe (10% owner) sold $1.3M of stock on Dec 17, 2025, filed Dec 19, 2025, scored 57 (moderate).
YCBD closed at $0.39 on Oct 9, 2026, 0% above its 52-week low and 83% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at cbdMD, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | Clark R. Crosnoe owner sell | $1.3M 550,701 shares | -67% | - |
Transactions
Every row filed, 22 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Clark R. Crosnoe owner | SOpen-market sale Common Stockindirect: By CRC Investment Fund LP | -461,725 | $2.31 | $1.1M | 361,400 | Dec 19, 2025 |
| Dec 17, 2025 | Clark R. Crosnoe owner | SOpen-market sale Common Stockindirect: By NM 2018 Trust | -69,875 | $2.34 | $164k | 56,875 | Dec 19, 2025 |
| Dec 17, 2025 | Clark R. Crosnoe owner | SOpen-market sale Common Stockindirect: By AMC Legacy Trust | -19,101 | $2.34 | $45k | 17,875 | Dec 19, 2025 |
| Nov 28, 2025 | Thomas Ronan Kennedy CEO and CFO | AGrant or award Common Stock | +445,000 | - | - | 513,722 | Dec 2, 2025 |
| May 16, 2025 | Jeffrey H Porter director | AGrant or award Common Stock | +1,572 | $0.00 | $0 | 1,572 | May 20, 2025 |
| May 16, 2025 | William F Raines III director | AGrant or award Common Stock | +1,572 | $0.00 | $0 | 12,104 | May 20, 2025 |
| May 16, 2025 | Kevin Charles Roe director | AGrant or award Common Stock | +1,572 | $0.00 | $0 | 25,135 | May 20, 2025 |
| May 16, 2025 | Bakari T. Sellers director | AGrant or award Common Stock | +1,572 | $0.00 | $0 | 2,752 | May 20, 2025 |
| May 16, 2025 | Scott G. Stephen director | AGrant or award Common Stock | +1,572 | $0.00 | $0 | 2,840 | May 20, 2025 |
| May 16, 2025 | Sibyl Nichole Swift director | AGrant or award Common Stock | +1,572 | $0.00 | $0 | 2,573 | May 20, 2025 |
| May 6, 2025 | Thomas Ronan Kennedy CEO and CFO | CConversion Common Stock | +67,869 | - | - | 74,501 | May 8, 2025 |
| May 6, 2025 | Jeffrey H Porter director | CConversion Common Stockindirect: By Porter Partners L.P. | +465,955 | - | - | 465,955 | May 8, 2025 |
| May 6, 2025 | Kevin Charles Roe director | CConversion Common Stock | +23,563 | - | - | 23,563 | May 8, 2025 |
| May 6, 2025 | Kevin Charles Roe director | CConversion 8% Series A Cumulative Convertible Preferred Stockderivative | -14,500 | - | - | 0 | May 8, 2025 |
| May 6, 2025 | Jeffrey H Porter director | CConversion Common Stockindirect: By Ben Joseph Partners | +61,750 | - | - | 61,750 | May 8, 2025 |
| May 6, 2025 | Thomas Ronan Kennedy CEO and CFO | CConversion 8% Series A Cumulative Convertible Preferred Stockderivative | -41,765 | - | - | 0 | May 8, 2025 |
| May 6, 2025 | Jeffrey H Porter director | CConversion Common Stockindirect: By Jeff Porter IRA- Beneficiary | +41,275 | - | - | 41,275 | May 8, 2025 |
| May 6, 2025 | Jeffrey H Porter director | CConversion Common Stockindirect: By Beneficiary of Trust | +4,550 | - | - | 4,550 | May 8, 2025 |
| May 6, 2025 | Jeffrey H Porter director | CConversion 8% Series A Cumulative Convertible Preferred Stockderivativeindirect: By Porter Partners L.P. | -286,741 | - | - | 0 | May 8, 2025 |
| May 6, 2025 | Jeffrey H Porter director | CConversion 8% Series A Cumulative Convertible Preferred Stockderivativeindirect: By Ben Joseph Partners | -38,000 | - | - | 0 | May 8, 2025 |
| May 6, 2025 | Jeffrey H Porter director | CConversion 8% Series A Cumulative Convertible Preferred Stockderivativeindirect: By Jeff Porter IRA- Beneficiary | -25,400 | - | - | 0 | May 8, 2025 |
| May 6, 2025 | Jeffrey H Porter director | CConversion 8% Series A Cumulative Convertible Preferred Stockderivativeindirect: By Beneficiary of Trust | -2,000 | - | - | 0 | May 8, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Clark R. Crosnoeowner
- Thomas Ronan KennedyCEO and CFO
- Jeffrey H Porterdirector
- William F Raines IIIdirector
- Kevin Charles Roedirector
- Bakari T. Sellersdirector
- Scott G. Stephendirector
- Sibyl Nichole Swiftdirector
Questions about YCBD
Answered from the filings on this page, as of the latest one.
Are insiders buying YCBD?
No. In the last 90 days no insider at cbdMD, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade YCBD on the open market?
Clark R. Crosnoe (10% owner) sold $1.3M of YCBD on Dec 17, 2025 and filed the Form 4 on Dec 19, 2025. InsiderTell scored 57 (moderate).
How many insiders file Form 4 at cbdMD, Inc.?
8 people have filed a Form 4 at cbdMD, Inc., among them Clark R. Crosnoe (10% owner), Thomas Ronan Kennedy (CEO and CFO), Jeffrey H Porter (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.